Published in Neurology on January 23, 2001
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis (2008) 3.91
Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology (2004) 3.44
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology (2014) 3.15
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol (2005) 1.81
Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol (2003) 1.81
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (2002) 1.78
Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS (2004) 1.75
Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol (2008) 1.74
Circulating proviral HIV DNA and HIV-associated dementia. AIDS (2005) 1.68
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology (2006) 1.66
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology (2015) 1.66
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev (2008) 1.52
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr (2011) 1.52
Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology (2007) 1.43
Antiretroviral neurotoxicity. J Neurovirol (2012) 1.43
Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.40
Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis (2010) 1.37
HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci (2008) 1.37
Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev (2009) 1.31
Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev (2013) 1.31
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis (2012) 1.31
Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs (2010) 1.31
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol (2004) 1.28
Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol (2004) 1.24
Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations. Br J Ophthalmol (2004) 1.19
Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci (2005) 1.12
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology (2013) 1.09
A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Curr Opin HIV AIDS (2011) 1.09
Roles of MCP-1 in development of HIV-dementia. Front Biosci (2008) 1.08
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther (2014) 1.08
Controversies in HIV-associated neurocognitive disorders. Lancet Neurol (2014) 1.07
Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol (2010) 1.07
Platelet-derived growth factor protects neurons against gp120-mediated toxicity. J Neurovirol (2008) 1.07
Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol (2006) 1.06
Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGb. Am J Pathol (2004) 1.05
Impact of HIV and aging on neuropsychological function. J Neurovirol (2012) 1.05
HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep (2008) 1.04
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord (2015) 1.03
Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex (2011) 1.02
Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS (2010) 1.02
Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol (2012) 1.00
11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol (2012) 1.00
Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase. Clin Neurosci Res (2006) 0.99
Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol (2009) 0.98
Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology (2013) 0.97
Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J Cereb Blood Flow Metab (2006) 0.97
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS One (2007) 0.97
Functional connectivity measured with magnetoencephalography identifies persons with HIV disease. Brain Imaging Behav (2012) 0.96
Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev (2013) 0.95
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology (2013) 0.95
Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res (2012) 0.95
Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr (2013) 0.95
Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. J Neuroimmune Pharmacol (2009) 0.94
Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol (2012) 0.94
Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996-2011. Neurology (2012) 0.93
Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One (2012) 0.93
Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men. PLoS One (2012) 0.93
Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr HIV Res (2012) 0.93
Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am J Pathol (2010) 0.92
Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92
HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol (2010) 0.92
Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral Res (2010) 0.91
Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder. J Biol Chem (2011) 0.90
Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol (2009) 0.89
4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis. J Neuroimmune Pharmacol (2009) 0.89
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol (2015) 0.88
Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. AIDS Patient Care STDS (2011) 0.88
Adaptive evolution of simian immunodeficiency viruses isolated from 2 conventional-progressor macaques with encephalitis. J Infect Dis (2008) 0.87
HIV stroke risk: evidence and implications. Ther Adv Chronic Dis (2013) 0.86
Verbal memory declines more rapidly with age in HIV infected versus uninfected adults. J Clin Exp Neuropsychol (2014) 0.86
Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia. BMC Infect Dis (2009) 0.86
Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neurovirol (2014) 0.86
Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages. J Neurovirol (2008) 0.85
The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India. J Neurovirol (2015) 0.85
Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy. AIDS Res Treat (2012) 0.84
Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J Neurovirol (2013) 0.84
PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice. J Cereb Blood Flow Metab (2014) 0.84
Methods to study monocyte migration induced by HIV-infected cells. Methods Mol Biol (2009) 0.84
PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol (2010) 0.84
Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans. BMC Res Notes (2010) 0.84
Simplification of the research diagnosis of HIV-associated sensory neuropathy. HIV Clin Trials (2009) 0.84
The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates. PLoS One (2014) 0.84
Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS One (2012) 0.84
The Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years. J Acquir Immune Defic Syndr (2014) 0.83
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND. Mol Neurobiol (2015) 0.83
HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways. PLoS One (2013) 0.83
Impact of age on markers of HIV-1 disease. Future Virol (2013) 0.82
HIV leucoencephalopathy and TNFalpha expression in neurones. J Neurol Neurosurg Psychiatry (2005) 0.82
Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice. Am J Transl Res (2009) 0.82
Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One (2012) 0.81
Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field. PLoS One (2013) 0.81
Unmasking of PML by HAART: unusual clinical features and the role of IRIS. J Neuroimmunol (2009) 0.81
Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance. Antiviral Res (2012) 0.81
Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Arch Clin Neuropsychol (2011) 0.80
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60
National health and nutrition examination I--epidemiologic follow-up survey. Public Health Rep (1983) 5.42
Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem (1990) 4.75
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
10 years after NHANES I: report of initial followup, 1982-84. Public Health Rep (1986) 4.11
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol (2000) 3.67
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology (1993) 3.53
Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med (1990) 3.52
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J (1998) 3.13
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med (1998) 2.99
Shortage of organs for transplantation. BMJ (1996) 2.97
Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med (1987) 2.93
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A (1998) 2.89
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75
Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry (2000) 2.70
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr (2002) 2.70
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology (2000) 2.64
The human interferon alpha/beta receptor: characterization and molecular cloning. Cell (1994) 2.63
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS (2005) 2.48
Clinical-neuropathologic correlation in HIV-associated dementia. Neurology (1993) 2.47
Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging (2008) 2.46
A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry (1989) 2.44
Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology (2010) 2.41
Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature (1996) 2.34
Cell interaction between compartments establishes the proximal-distal axis of Drosophila legs. Nature (1994) 2.33
Ocular motor function in motor neuron disease. Neurology (1992) 2.27
Reactions of adult and teenaged smokers to the Massachusetts tobacco tax. Am J Public Health (1998) 2.23
Cognitive outcome after coronary artery bypass: a one-year prospective study. Ann Thorac Surg (1997) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol (1999) 2.11
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10
Hypoperfusion of Wernicke's area predicts severity of semantic deficit in acute stroke. Ann Neurol (2001) 2.09
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology (2006) 2.06
A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage (2004) 2.05
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology (2007) 2.05
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Velocity storage in the vestibulo-ocular reflex arc (VOR). Exp Brain Res (1979) 2.04
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet (1988) 1.97
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology (1988) 1.94
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Homeotic genes of the Bithorax complex repress limb development in the abdomen of the Drosophila embryo through the target gene Distal-less. Cell (1992) 1.91
Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol (2001) 1.91
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology (2007) 1.90
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res (2000) 1.89
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS (2001) 1.84
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Immunisation of monkeys (Macaca fascicularis) with antigens purified from Streptococcus mutans. Br Dent J (1982) 1.81
Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol (2004) 1.78
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science (1996) 1.76
Age, Alzheimer disease, and brain structure. Neurology (2009) 1.75
An overview of the immune system. Lancet (2001) 1.73
Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol (1993) 1.73
Analysis of antigenic types appearing in first relapse populations of clones of Trypanosoma brucei. Parasitology (1981) 1.73